These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 15257714

  • 1. Intraindividual consistency of the activated protein C resistance phenotype.
    Tosetto A, Simioni M, Madeo D, Rodeghiero F.
    Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
    [Abstract] [Full Text] [Related]

  • 2. The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
    Tosetto A, Castaman G, Cappellari A, Rodeghiero F.
    Thromb Haemost; 2000 Nov; 84(5):811-4. PubMed ID: 11127861
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G, Tosetto A, Simioni M, Ruggeri M, Madeo D, Rodeghiero F.
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [Abstract] [Full Text] [Related]

  • 4. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL, Welsh CH, Qamar Z, Marlar RA.
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [Abstract] [Full Text] [Related]

  • 5. The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis.
    Tosetto A, Missiaglia E, Gatto E, Rodeghiero F.
    Thromb Haemost; 1997 Aug; 78(2):859-63. PubMed ID: 9268185
    [Abstract] [Full Text] [Related]

  • 6. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S, Keskin N, Keskin A, Atalay E.
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of phenotype resistance to activated protein C (APC resistance)].
    Hudecek J, Ivanková J, Dobrotová M, Hybenová J, Pullmann R, Kubisz P.
    Vnitr Lek; 1999 Dec; 45(12):723-8. PubMed ID: 10951849
    [Abstract] [Full Text] [Related]

  • 8. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
    Bossone A, Cappucci F, D'Andrea G, Brancaccio V, Cibelli G, Iannaccone L, Grandone E, Margaglione M.
    Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
    [Abstract] [Full Text] [Related]

  • 9. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [Abstract] [Full Text] [Related]

  • 10. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B.
    Semin Thromb Hemost; 1999 Sep; 25(3):273-89. PubMed ID: 10443959
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G, Valverde S.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors.
    Taralunga C, Gueguen R, Visvikis S, Regnault V, Sass C, Siest G, Lecompte T, Wahl D.
    Br J Haematol; 2004 Aug; 126(3):392-7. PubMed ID: 15257712
    [Abstract] [Full Text] [Related]

  • 13. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón L.
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [Abstract] [Full Text] [Related]

  • 14. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S, Kalkan U, Bolaman Z, Sanci M, Yüksel H, Odabaşi AR.
    Gynecol Obstet Invest; 2007 Oct; 64(2):89-94. PubMed ID: 17314487
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
    Schöni R, Quehenberger P, Wu JR, Wilmer M.
    Thromb Res; 2007 Oct; 119(1):17-26. PubMed ID: 16934314
    [Abstract] [Full Text] [Related]

  • 17. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
    Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, Almawi WY.
    Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
    [Abstract] [Full Text] [Related]

  • 18. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K, Svensson PJ, Ohlin AK.
    Thromb Res; 2007 Sep; 121(2):145-51. PubMed ID: 17499343
    [Abstract] [Full Text] [Related]

  • 19. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A, Moreno-Hernández M, Ruiz-de-Chávez-Ochoa A, Monroy-García R, Majluf-Cruz K, Guardado-Mendoza R, Molina-Avila I, Isordia-Salas I, Corona-de la Peña N, Vargas-Vorackova F, Vela-Ojeda J, García-Chávez J.
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [Abstract] [Full Text] [Related]

  • 20. Congenital and acquired activated protein C resistance.
    Nicolaes GA, Dahlbäck B.
    Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.